A urine test may boost HIV prevention — a trial puts it to the test

NCT ID NCT07725679

Not yet recruiting Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a simple urine test can help adolescent girls and young women in Kenya stay on track with their daily HIV prevention pills (PrEP). Participants who get the test will receive immediate feedback on their drug levels during counseling sessions. Researchers will compare urine test results between the group that gets the test and the group that receives standard counseling alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a urine point-of-care test for tenofovir with drug-level feedback counseling
What this could lead to: If effective, this simple urine test could help women stay on PrEP and reduce new HIV infections.
What could go wrong: This is a single-site trial with 400 participants, so results may not apply broadly. The test only measures recent adherence and does not guarantee protection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates